U.N. Commission Approves WHO Recommendation to Reclassify Cannabis

U.N. Commission Approves WHO Recommendation to Reclassify Cannabis

by Mike Goral
December 09, 2020

The United Nations Commission on Narcotic Drugs accepted a World Health Organization (WHO) recommendation to remove cannabis and cannabis resin from Schedule IV of the 1961 Single Convention on Narcotic Drugs. The approval carries broad symbolic significance for medical cannabis, and it may boost medical cannabis legalization efforts around the world. Many experts believe that this may encourage countries to reevaluate how cannabis is classified in their own jurisdiction.

It is interesting to note that the G20, for the most part, approved this recommendation, including the U.S., U.K., Germany, Italy and France. However, Japan and Russia did not vote in favor of the measure. Therefore, the U.S. is now on record in favor of medical declassification of cannabis under the Trump administration, paving the way for a more favorable treatment under the Biden administration.

To learn more, reach out to our experts.

December 09, 2020

Stay In Touch

Sign up to stay up-to-date with the latest accounting regulations, best practices, industry news and technology insights to run your business.

More News and Insights
Design the Right Endowment Spending Policy for Your School
Learn how you can reimagine your school’s endowment.

May 6, 2021 | 10:00 AM - 11:00 AM PST
Lease Accounting: What Are Auditors Seeing?
Manage the challenges of ASC 842 and stay in compliance.

April 29, 2021 | 10:00 AM - 11:00 AM PST
MSO Receives Major Tax Refund
Case Study
A healthcare company struggled to write off self-pay bad debt until switching its deduction method.

April 14, 2021